The average weight regain was approximately two-thirds of total weight lost within one year of discontinuation
While mild to moderate nausea is expected with GLP-1 therapy, certain symptoms warrant prompt medical evaluation
Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors
Regular use may help reduce hyperpigmentation, freckles, melasma, and age spots , leading to a more even and luminous complexion
The Health and Human Services budget document notes that the GLP-1 coverage chaos comes after the outgoing Biden administration left the specifics of the drugs eligibility under Medicare and Medicaid up to the Trump administration
In other words, the gastrointestinal side effects were milder and less frequent than what researchers typically see with GLP-1 and GIP agonists